Abstract 5376: Antisense oligonucleotide targeting insulin-like growth factor-1 receptor (IGF-1R) enhances paclitaxel sensitivity in a castrate-resistant and paclitaxel-resistant prostate cancer model

Cancer Model ◽

Castrate Resistant ◽

234 Antisense oligonucleotide targeting Insulin-like Growth Factor-1 Receptor (IGF-1R) enhances paclitaxel sensitivity in a castrate-resistant and paclitaxel-resistant prostate cancer model

European Urology Supplements ◽

10.1016/s1569-9056(12)60231-0 ◽

2012 ◽

Vol 11 (1) ◽

pp. e234 ◽

Cited By ~ 1

Author(s):

J. Furukawa ◽

H. Miyake ◽

M. Fujisawa

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Cancer Model ◽

Castrate Resistant ◽

727 ANTISENSE OLIGONUCLEOTIDE TARGETING INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR ENHANCES PACLITAXEL SENSITIVITY IN A PACLITAXEL- RESISTANT PROSTATE CANCER MODEL

The Journal of Urology ◽

10.1016/j.juro.2011.02.1696 ◽

2011 ◽

Vol 185 (4S) ◽

Author(s):

Junya Furukawa ◽

Hideaki Miyake ◽

Masato Fujisawa ◽

Christopher Wraight ◽

Brett Monia ◽

...

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Cancer Model ◽

440 Effects of bispecific antisense oligonucleotide targeting both insulin-like growth factor binding proteins 2 and 5 on cell survival and apoptosis in prostate cancer model

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)80448-8 ◽

2004 ◽

Vol 2 (8) ◽

pp. 132

Author(s):

M. Signaevsky ◽

S. Kijama ◽

E. Beraldi ◽

M. Cox ◽

M. Gleave

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Cell Survival ◽

Binding Proteins ◽

Cancer Model ◽

Factor Binding ◽

Apigenin Attenuates Insulin-Like Growth Factor-I Signaling in an Autochthonous Mouse Prostate Cancer Model

Pharmaceutical Research ◽

10.1007/s11095-011-0625-0 ◽

2011 ◽

Vol 29 (6) ◽

pp. 1506-1517 ◽

Cited By ~ 26

Author(s):

Sanjeev Shukla ◽

Gregory T. MacLennan ◽

Pingfu Fu ◽

Sanjay Gupta

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Cancer Model ◽

Factor I ◽

Mouse Prostate ◽

Growth Factor I ◽

Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer

The Prostate ◽

10.1002/pros.21054 ◽

2009 ◽

Vol 70 (2) ◽

pp. 206-218 ◽

Cited By ~ 13

Author(s):

Junya Furukawa ◽

Christopher J. Wraight ◽

Susan M. Freier ◽

Eigan Peralta ◽

Lynne M. Atley ◽

...

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Insulin Like Growth Factor

A phase 2 study of OSI-906 (linsitinib, an insulin-like growth factor receptor-1 inhibitor) in patients with asymptomatic or mildly symptomatic (non-opioid requiring) metastatic castrate resistant prostate cancer (CRPC)

Investigational New Drugs ◽

10.1007/s10637-018-0574-0 ◽

2018 ◽

Vol 36 (3) ◽

pp. 451-457 ◽

Cited By ~ 6

Author(s):

Pedro Barata ◽

Matthew Cooney ◽

Allison Tyler ◽

John Wright ◽

Robert Dreicer ◽

...

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Phase 2 ◽

Phase 2 Study ◽

Castrate Resistant

An evaluation of clusterin antisense inhibitor OGX-011 in combination with the second-generation antiandrogen MDV3100 in a castrate-resistant prostate cancer model.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.4502 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 4502-4502 ◽

Cited By ~ 3

Author(s):

H. Matsumoto ◽

H. Kuruma ◽

A. Zoubeidi ◽

L. Fazli ◽

M. E. Gleave

Keyword(s):

Prostate Cancer ◽

Second Generation ◽

Cancer Model ◽

Castrate Resistant ◽

235 Clusterin knockdown synergizes activity of second generation anti-androgen, MDV3100, through enhancing AR degradation and repression of FKBP52 in castrate resistant prostate cancer model

European Urology Supplements ◽

10.1016/s1569-9056(12)60232-2 ◽

2012 ◽

Vol 11 (1) ◽

pp. e235

Author(s):

H. Matsumoto ◽

H. Kuruma ◽

A. Zoubeidi ◽

A. Zardan ◽

L. Fazli ◽

...

Keyword(s):

Prostate Cancer ◽

Second Generation ◽

Cancer Model ◽

Castrate Resistant ◽

125 CLUSTERIN ANTISENSE INHIBITOR OGX-011 SYNERGIZES ACTIVITY OF SECOND GENERATION ANTI-ANDROGEN, MDV3100, IN CASTRATE RESISTANT PROSTATE CANCER MODEL

The Journal of Urology ◽

10.1016/j.juro.2011.02.192 ◽

2011 ◽

Vol 185 (4S) ◽

Author(s):

Hiroaki Matsumoto ◽

Hidetoshi Kuruma ◽

Amina Zoubeidi ◽

Ladan Fazli ◽

Martin Gleave

Keyword(s):

Prostate Cancer ◽

Second Generation ◽

Cancer Model ◽

Castrate Resistant ◽

Abstract 2640: Characterization and targeted therapy using patient tumor-derived 3-D spheroids in a metastatic castrate resistant prostate cancer model

10.1158/1538-7445.am2021-2640 ◽

2021 ◽

Author(s):

Adam M. Kase ◽

Winston Tan ◽

John A. Copland

Keyword(s):

Prostate Cancer ◽

Targeted Therapy ◽

Cancer Model ◽

Castrate Resistant ◽